Molecular imaging and psychiatric pathologies

Home › The Institute › Molecular imaging and psychiatric pathologies

The development of neuroimaging techniques has led in recent years to a better understanding of pathophysiological processes of psychiatric pathologies. In parallel, clinical assessment tools have been developed, including the study of quality of life and symptomatic and functional remission. The study of the molecular substrates of quality of life and functional remission evaluated using standardized tools aims here to better understand how to improve the evolution and the prognosis of psychiatric pathologies (depression, schizophrenia).